Camden, Delaware – January 23, 2025 – NormaxBio, a pioneering biotechnology company at the forefront of innovative immunotherapies, today announced a strategic partnership with Prestel & Partner, the global leader in Family Office Forums. This collaboration will see NormaxBio’s groundbreaking Educated Antigen Receptor Therapy (EARTh) for People Living with Cancer featured at nine prestigious family office events worldwide.
NormaxBio’s EARTh therapy represents a significant leap forward in personalized cancer treatment. This innovative approach harnesses the patient’s own immune system, educating and enhancing its ability to recognize and eliminate cancer cells with unprecedented precision. Unlike traditional treatments that can be broadly toxic, EARTh therapy is designed to target cancer cells specifically, minimizing side effects and maximizing therapeutic benefit.
“We are thrilled to partner with Prestel & Partner to bring awareness of our life-changing EARTh therapy to a global network of influential families,” said Peter Jensen, CEO at NormaxBio. “These forums attract forward-thinking individuals who understand the power of innovation in healthcare and we believe that EARTh therapy has the potential to revolutionize cancer care and improve the lives of countless patients worldwide.”
The partnership with Prestel & Partner provides NormaxBio with a unique platform to engage with family offices, high-net-worth individuals (UHNWIs), and global investors who are increasingly interested in advancing medical breakthroughs. Prestel & Partner’s carefully curated events are renowned for their exclusivity, attracting a network of key decision-makers who value in-depth discussions, knowledge sharing, and impactful investment opportunities.
Throughout the nine-event series, NormaxBio will participate in keynote addresses, panel discussions, and networking opportunities, educating attendees about the scientific principles and clinical potential of EARTh therapy. These platforms will allow normaxBio to highlight how EARTh therapy embodies the values of long-term, positive impact for global wellbeing.
The Prestel & Partner events are strategically located in global hubs, including Dubai, Singapore, Istanbul, London, Wiesbaden, New York, Cayman Islands, Zurich, and Riyadh, allowing NormaxBio to reach a diverse international audience. NormaxBio’s EARTh campaign is aligned to the forward thinking innovation values of the Prestel and Partner forum, providing unique access to the global wealth community.
About NormaxBio
NormaxBio is a biotechnology company dedicated to developing innovative immunotherapies for the treatment of cancer. Its proprietary Educated Antigen Receptor Therapy (EARTh) platform is a pioneering approach to personalized cancer care, leveraging the power of the immune system to selectively destroy cancer cells. For more information, visit normaxbiomed.com
About Prestel & Partner
Prestel & Partner is the global leader in Family Office Forums, offering a private platform for networking, sharing, and learning opportunities on the most pertinent family office and investment themes. Their events bring together single family offices, UHNWIs, and a select group of experts. For more information, visit prestelandpartner.com.
Normax Contact:
Peter A. Jensen
